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Diabetic Retinopathy
• Diabetic Retinopathy is a 
leading cause of 
blindness in individuals   
< 65 years of age
• Can be totally 
asymptomatic until there 
is significant visual loss
• Blindness can be 
prevented by timely laser 
treatment
Diabetic Retinopathy Screening
• Public health service - to identify 
individuals affected by disease or at risk
• Undergo tests or treatment to reduce risk 
of the disease or complications
• There has been no systematic screening 
for diabetic retinopathy (DR) in Hong Kong
Inverse care law
• Julian Tudor Hart ( 30 years ago) (Lancet)
• perverse relationship between the need for health 
care and its actual utilization
• i.e. those who most need medical care are least 
likely to receive it 
• Conversely, those with least need of health care tend to 
use health services more (and more effectively). 
Objectives:
? Introduce effective and cost-effective 
screening programme to screen naïve patients 
with diabetes mellitus ( DM) for retinopathy.
? To refer appropriate patients to SOPD 
(Ophthalmology &/or General medicine) and 
administer early treatment to prevent visual 
loss.
? To see whether paying a fee deterred patients 
from attending the screening programme.
Diabetic Retinopathy Screening
• A randomized controlled trial
• Phone-contacted 4619 patients with DM 
• HK West cluster
• Two groups :
‘PAY group’ ‘FREE group’
(a fee of $ 60.00)           (not required to pay any fees) 
All patients underwent screening test and stereoscopic 
fundus photography. 
DR Study – Flow Chart 
(in Aberdeen clinic)
The screening process:
Registration
Check visual acuity
Check A/C Depth
Dilate pupils
Take fundus photos
The Screening Process
1. Registration
- explaining the consent forms
- collecting the payments
- issuing the receipts
The Screening Process
2. To check patients’ visual acuities
- ETDRS chart
- pinhole vision
The Screening Process
3. To check patients’ A/C Depths & apply dilation    
eye drops
- no drops are applied if patients’ angles are         
narrow
The Screening Process
4. Taking fundus photographs 
- 2 fields in each eye (macula & optic disc)
The Screening Process
Grading Protocol
• Image Quality
• Artifacts
• Severity of the 
disease
• Other eye diseases
• Arbitration
• Quality Assurance
Diabetic Retinopathy Grading Standard
Grade International Term Features Action
R0 No diabetic retinopathy Normal retina Annual screening
R1 Mild non-proliferative 
diabetic retinopathy
Hemorrhages and micro aneurysms only Annual screening
R2 Moderate non-
proliferative diabetic 
retinopathy
Extensive micro aneurysms (MAs), intraretinal hemorrhages, 
and hard exudates
Appt within 13 
weeks
R2 Severe non-
proliferative diabetic 
retinopathy
Venous abnormalities, large blot hemorrhages, cotton wool 
spots (small infarcts), venous beading, venous loop, venous 
reduplication, and IRMA
Appt within 13 
weeks
R3 Proliferative diabetic 
retinopathy
New vessel formation either at the disc (NVD) or elsewhere 
(NVE).
Appt within 2 
weeks
R3 Pre-retinal fibrosis ±
tractional retinal 
detachment
Extensive fibro vascular proliferation, retinal detachment, pre-
retinal or vitreous hemorrhage, glaucoma and subhyaloid 
hemorrhage
Appt within 2 
weeks
M0 No maculopathy No maculopathy Annual screening
M1 Maculopathy Exudative : leakage, retinal thickening, MAs,HEs 
Ischemic :  featureless macula with NVE and poor VA
Milder forms: 
•exudate ≤1DD of centre of fovea 
•circinate or group of exudates within macula 
•any MAs or hemorrhage ≤1DD of centre of fovea only if 
associated with a best VA of ≤ 6/12
•retinal thickening ≤1DD of centre of fovea  
Appt within 13 
weeks
P Photocoagulation Small retinal scars through out the peripheral retina. Appt < 2 weeks
U Un-gradable Ungradable : cataract or other lesions -referred for assessment Appt < 4 weeks








Total no. of patients screened = 2221
Level of Retinopathy Total %
R0 1489 67.71%
R1 368 16.57%
R0 or R1, M 54 2.43%
R2 24 1.08%
R2, M 23 1.04%
R3 2 0.09%
U 248 11.17%
P 4 0.18%
Any Retinopathy 475 21.38%
Total 2221 100.00%
Screening results:
Overall results
• One in 5 patients has some retinopathy
• One in 20 patients has SIGHT 
THREATENING diabetic retinopathy
Outcome
• Out of the 2221 patients screened, 475 
(21%) were referred to hospitals, some to 
general ophthalmology clinic and some to 
retinal clinic
Is there a difference between free 
group and the pay group?
FREE 
group
PAY 
group
Total
• Total no. of phone 
calls
2312 2307 4619
• No. of patients who 
took part in study
1300 1259 2559
• % of patients who 
accepted invitation
94.6% 90.9%
• % of patients who 
showed up
93.3% 90.1%
• Response rate 88.3% 82.0%
Screening results:
Level of 
Retinopathy
Free
Group %
Pay
Group % Total %
R0 740 63.41% 749 71.06% 1489 67.71%
R0, M** 2 0.17% 7 0.66% 9 0.41%
R1 212 18.17% 156 14.80% 368 16.57%
R1, M** 31 2.66% 14 1.33% 45 2.17%
R2 14 1.20% 10 0.95% 24 1.08%
R2, M** 13 1.11% 10 0.95% 23 1.04%
R3 1 0.09% 1 0.09% 2 0.09%
U* 147 12.60% 101 9.58% 248 11.17%
U*,M** 5 0.43% 4 0.38% 9 0.41%
P*** 2 0.17% 2 0.19% 4 0.18%
Total 1167 100% 1054 100% 2221 100%
Screening results:
FREE group PAY group Difference ( 95% 
Confidence Interval)
• R0
retinopathy
69.2% 75.8% 6.6% (2.8-10.3%)
• R1
retinopathy
20.2% 15.7% 4.5% (1.2-7.7%)
• No. of 
patients
who needed 
referral
5.9% 4.9% 1.0%(- 1.0-2.9%)
Screening results:
Summary
1. More patients in free group turned up for 
screening
2. Pay group has more patients with no 
retinopathy
3. Tendency of free group to have higher 
levels of retinopathy, therefore
‘Inverse care law’ seemed to apply
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